Cisapride Powder
NDC Package 12578-431-00
Package Information
Cisapride powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Janssen Pharamceutica Nv, this product is identified by NDC 12578-431.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 12578 - Janssen Pharamceutica Nv
- 12578-431 -
- 12578-431-00 - 25 kg in 1 DRUM
- 12578-431 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 12578-431-00 identifies a specific commercial package of 25 kg in 1 drum of Cisapride (UNFINISHED drug), a bulk ingredient labeled by Janssen Pharamceutica Nv. This powder is formulated for use and contains cisapride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Janssen Pharamceutica Nv on August 10, 1999. The current certification is valid through December 31, 2026.
How is this Janssen Pharamceutica Nv product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 12578043100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.